ARTICLE | Company News
Sirnaomics, Guangdong Zhongsheng deal
July 4, 2011 7:00 AM UTC
Guangdong and Sirnaomics partnered to develop and commercialize STP601 in China and Southeast Asia to treat diabetic retinopathy and age-related macular degeneration (AMD). Sirnaomics will receive up...